122 related articles for article (PubMed ID: 25089601)
21. Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study.
Uprety D; Bista A; Chennamadhavuni A; Niroula A; Jafri SIM; Smith A; Arjyal L
Melanoma Res; 2018 Feb; 28(1):56-60. PubMed ID: 29023264
[TBL] [Abstract][Full Text] [Related]
22. A case series of paediatric and adolescent melanoma.
Stefanaki C; Soura E; Plaka M; Chasapi V; Polydorou D; Antoniou C; Stratigos A
Eur J Dermatol; 2018 Feb; 28(1):120-122. PubMed ID: 29180317
[No Abstract] [Full Text] [Related]
23. Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
Pflugfelder A; Eigentler TK; Keim U; Weide B; Leiter U; Ikenberg K; Berneburg M; Garbe C
PLoS One; 2011 Feb; 6(2):e16882. PubMed ID: 21359173
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy and biologic therapies for melanoma: do they work?
Jilaveanu LB; Aziz SA; Kluger HM
Clin Dermatol; 2009; 27(6):614-25. PubMed ID: 19880049
[TBL] [Abstract][Full Text] [Related]
27. Pediatric and Adolescent Melanoma: A National Cancer Data Base Update.
Lorimer PD; White RL; Walsh K; Han Y; Kirks RC; Symanowski J; Forster MR; Sarantou T; Salo JC; Hill JS
Ann Surg Oncol; 2016 Nov; 23(12):4058-4066. PubMed ID: 27364504
[TBL] [Abstract][Full Text] [Related]
28. Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta-analysis.
Murchie P; Amalraj Raja E; Brewster DH; Iversen L; Lee AJ
Eur J Cancer; 2017 Nov; 86():373-384. PubMed ID: 29100192
[TBL] [Abstract][Full Text] [Related]
29. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
30. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
31. [Treatment of metastasized malignant melanoma].
Kamanabrou D
Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Long GV; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Schadendorf D; Lesimple T; Plummer R; Ji R; Zhang P; Mookerjee B; Legos J; Kefford R; Dummer R; Kirkwood JM
N Engl J Med; 2017 Nov; 377(19):1813-1823. PubMed ID: 28891408
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
[TBL] [Abstract][Full Text] [Related]
35. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).
Schadendorf D; Ascierto PA; Haanen J; Espinosa E; Demidov L; Garbe C; Guida M; Lorigan P; Chiarion-Sileni V; Gogas H; Maio M; Fierro MT; Hoeller C; Terheyden P; Gutzmer R; Guren TK; Bafaloukos D; Rutkowski P; Plummer R; Waterston A; Kaatz M; Mandala M; Marquez-Rodas I; Muñoz-Couselo E; Dummer R; Grigoryeva E; Young TC; Nathan P
Eur J Cancer; 2019 Nov; 121():144-153. PubMed ID: 31581055
[TBL] [Abstract][Full Text] [Related]
37. Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2.
Moreno-Ramírez D; Alés-Martínez M; Ferrándiz L
Cancer Immunol Immunother; 2014 Nov; 63(11):1229-30. PubMed ID: 25056817
[No Abstract] [Full Text] [Related]
38. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
39. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Ribas A; Puzanov I; Dummer R; Schadendorf D; Hamid O; Robert C; Hodi FS; Schachter J; Pavlick AC; Lewis KD; Cranmer LD; Blank CU; O'Day SJ; Ascierto PA; Salama AK; Margolin KA; Loquai C; Eigentler TK; Gangadhar TC; Carlino MS; Agarwala SS; Moschos SJ; Sosman JA; Goldinger SM; Shapira-Frommer R; Gonzalez R; Kirkwood JM; Wolchok JD; Eggermont A; Li XN; Zhou W; Zernhelt AM; Lis J; Ebbinghaus S; Kang SP; Daud A
Lancet Oncol; 2015 Aug; 16(8):908-18. PubMed ID: 26115796
[TBL] [Abstract][Full Text] [Related]
40. [Current aspects in the prognosis of advanced melanoma].
Sirokay-Kohlmeyer J
Hautarzt; 2018 Mar; 69(3):249-259. PubMed ID: 29396638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
